DK1718673T3 - Fremgangsmåde til rensning af albumin omfattende et nanofiltreringstrin, oplösning og sammensætning til terapeutisk anvendelse, som indeholder det - Google Patents

Fremgangsmåde til rensning af albumin omfattende et nanofiltreringstrin, oplösning og sammensætning til terapeutisk anvendelse, som indeholder det

Info

Publication number
DK1718673T3
DK1718673T3 DK05731028T DK05731028T DK1718673T3 DK 1718673 T3 DK1718673 T3 DK 1718673T3 DK 05731028 T DK05731028 T DK 05731028T DK 05731028 T DK05731028 T DK 05731028T DK 1718673 T3 DK1718673 T3 DK 1718673T3
Authority
DK
Denmark
Prior art keywords
solution
composition
therapeutic use
use containing
nanofiltration step
Prior art date
Application number
DK05731028T
Other languages
Danish (da)
English (en)
Inventor
Paul Boulange
Sami Chtourou
Stephane Boyer
Roland Schmitthaeusler
Bruno Padrazzi
Original Assignee
Fractionnement Et De Biotechno
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34834103&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1718673(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fractionnement Et De Biotechno filed Critical Fractionnement Et De Biotechno
Application granted granted Critical
Publication of DK1718673T3 publication Critical patent/DK1718673T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Water Supply & Treatment (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK05731028T 2004-02-27 2005-02-23 Fremgangsmåde til rensning af albumin omfattende et nanofiltreringstrin, oplösning og sammensætning til terapeutisk anvendelse, som indeholder det DK1718673T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0402001A FR2866890B1 (fr) 2004-02-27 2004-02-27 Procede de purification d'albumine comprenant une etape de nanofiltration, solution et composition a usage therapeutique la contenant
PCT/FR2005/000416 WO2005090402A1 (fr) 2004-02-27 2005-02-23 Procede de purificaton d’albumine comprenant une etape de nanofiltration, solution et composition a usage therapeutique la contenant

Publications (1)

Publication Number Publication Date
DK1718673T3 true DK1718673T3 (da) 2008-01-14

Family

ID=34834103

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05731028T DK1718673T3 (da) 2004-02-27 2005-02-23 Fremgangsmåde til rensning af albumin omfattende et nanofiltreringstrin, oplösning og sammensætning til terapeutisk anvendelse, som indeholder det

Country Status (16)

Country Link
US (3) US20070161122A1 (https=)
EP (1) EP1718673B1 (https=)
JP (2) JP4979571B2 (https=)
AT (1) ATE373014T1 (https=)
AU (1) AU2005223418B2 (https=)
BR (1) BRPI0507886A (https=)
CA (1) CA2557174C (https=)
CY (1) CY1107082T1 (https=)
DE (1) DE602005002461T2 (https=)
DK (1) DK1718673T3 (https=)
ES (1) ES2294696T3 (https=)
FR (1) FR2866890B1 (https=)
IL (1) IL177286A (https=)
PL (1) PL1718673T3 (https=)
PT (1) PT1718673E (https=)
WO (1) WO2005090402A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2866890B1 (fr) * 2004-02-27 2008-04-04 Lab Francais Du Fractionnement Procede de purification d'albumine comprenant une etape de nanofiltration, solution et composition a usage therapeutique la contenant
FR2887883B1 (fr) 2005-06-29 2007-08-31 Lab Francais Du Fractionnement Procede de separation des proteines fibrinogene, facteur xiii et colle biologique d'une fraction plasmatique solubilisee et de preparation de concentres lyophilises desdites proteines
FR2894831B1 (fr) 2005-12-16 2008-02-15 Lab Francais Du Fractionnement Colle biologique exempte de thrombine et son utilisation comme medicament.
ES2294976B1 (es) * 2007-11-12 2008-12-16 Grifols, S.A. "procedimiento de obtencion de albumina humana de alta eficacia para su uso en terapia de detoxificacion".
KR20140093603A (ko) 2010-12-30 2014-07-28 라보라토이레 프란카이즈 듀 프락티온네먼트 에트 데스 바이오테크놀로지스 병원체 불활성화제로서의 글리콜
FR3004451B1 (fr) * 2013-04-11 2015-12-11 Lab Francais Du Fractionnement Procede de preparation d'une solution de proteine c viralement securisee par une double etape de nanofiltration
US20180028593A1 (en) * 2014-03-21 2018-02-01 Boreal Invest Terminal nanofiltration of solubilized protein compositions for removal of immunogenic aggregates
FR3040882A1 (fr) * 2015-09-10 2017-03-17 Lab Francais Du Fractionnement Composition liquide d'albumine humaine a usage therapeutique
WO2021155142A1 (en) * 2020-01-30 2021-08-05 Fresenius Medical Care Holdings, Inc. Techniques for modelling and optimizing dialysis toxin displacer compounds
US11739166B2 (en) 2020-07-02 2023-08-29 Davol Inc. Reactive polysaccharide-based hemostatic agent
US12161777B2 (en) 2020-07-02 2024-12-10 Davol Inc. Flowable hemostatic suspension
EP4267210A1 (en) 2020-12-28 2023-11-01 Davol Inc. Reactive dry powdered hemostatic materials comprising a protein and a multifunctionalized modified polyethylene glycol based crosslinking agent

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9019919D0 (en) 1990-09-12 1990-10-24 Delta Biotechnology Ltd Purification of proteins
FR2672604B1 (fr) * 1991-02-07 1995-05-05 Pasteur Merieux Serums Vacc Procede pour isoler de l'albumine humaine a partir du surnageant iv, notamment iv-4, ou de la fraction v de cohn ou d'un surnageant ou fraction analogue.
US5849874A (en) * 1991-07-12 1998-12-15 Gist-Brocades, N.V. Process for the purification of serum albumin
US5440018A (en) 1992-05-20 1995-08-08 The Green Cross Corporation Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same
JPH06279296A (ja) * 1993-03-25 1994-10-04 Asahi Chem Ind Co Ltd 血漿分画製剤中から蛋白質会合物の除去方法
SE9500724D0 (sv) * 1994-06-23 1995-02-24 Pharmacia Ab Filtrering
US6210683B1 (en) * 1997-09-05 2001-04-03 Merck & Co., Inc. Stabilizers containing recombinant human serum albumin for live virus vaccines
JP4798832B2 (ja) * 2000-10-24 2011-10-19 一般財団法人化学及血清療法研究所 ヒト血清アルブミン多量体の除去方法
DE60121196T2 (de) * 2000-10-24 2007-07-12 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Verfahren zur monomerisierung von humanen serumalbumin-polymeren
US6806355B2 (en) * 2001-08-14 2004-10-19 Statens Serum Institut Purification process for large scale production of Gc-globulin, the Gc-globulin produced hereby, a use of Gc.globulin and a Gc-globulin medicinal product
DE10211632A1 (de) * 2002-03-15 2003-10-09 Aventis Behring Gmbh Verfahren zur Abtrennung von Viren aus einer Proteinlösung durch Nanofiltration
AU2004228847B2 (en) * 2003-04-09 2010-06-17 Km Biologics Co., Ltd. Process for producing albumin preparation
FR2866890B1 (fr) * 2004-02-27 2008-04-04 Lab Francais Du Fractionnement Procede de purification d'albumine comprenant une etape de nanofiltration, solution et composition a usage therapeutique la contenant

Also Published As

Publication number Publication date
CA2557174A1 (fr) 2005-09-29
BRPI0507886A (pt) 2007-08-07
EP1718673A1 (fr) 2006-11-08
AU2005223418B2 (en) 2008-12-18
JP2007535495A (ja) 2007-12-06
US10562957B2 (en) 2020-02-18
PL1718673T3 (pl) 2008-03-31
IL177286A0 (en) 2006-12-10
EP1718673B1 (fr) 2007-09-12
ES2294696T3 (es) 2008-04-01
US20070161122A1 (en) 2007-07-12
FR2866890B1 (fr) 2008-04-04
AU2005223418A1 (en) 2005-09-29
CA2557174C (fr) 2013-04-30
DE602005002461T2 (de) 2008-06-12
CY1107082T1 (el) 2012-10-24
ATE373014T1 (de) 2007-09-15
DE602005002461D1 (de) 2007-10-25
FR2866890A1 (fr) 2005-09-02
US20170166626A1 (en) 2017-06-15
JP4979571B2 (ja) 2012-07-18
US9611311B2 (en) 2017-04-04
WO2005090402A1 (fr) 2005-09-29
IL177286A (en) 2012-08-30
JP2012102115A (ja) 2012-05-31
US20150152162A1 (en) 2015-06-04
PT1718673E (pt) 2007-12-13

Similar Documents

Publication Publication Date Title
CY1107082T1 (el) Μεθοδος καθαρισμου αλβουμινης η οποια περιλαμβανει ενα σταδιο νανοδιηθησης, διαλυμα και συνθεση για θεραπευτικη χρηση που περιεχουν την ιδια
ATE384742T1 (de) Verfahren zur reinigung von preproinsulin
EA200600014A1 (ru) Способ отгонки соводяным паром из газовых потоков
ATE331705T1 (de) Alpha-aminosäure-derivate, verfahren zu deren herstellung sowie deren verwendung als dipeptidylpeptidase-iv inhibitoren (dpp iv)
BRPI0412321A (pt) limpeza de membranas de filtração com peróxidos
DK1409539T3 (da) Fremgangsmåde til fremstilling af en proteinholdig fraktion beriget med beta-TGF i aktiveret form, en proteinfraktion og terapeutiske anvendelser
ATE462427T1 (de) Verwendung von treprostinil zur behandlung von neuropathischen diabetischen fussgeschwüren
NO20050251L (no) Fremgangsmate for a rense Fischer-Tropsch-utvunnet vann
ATE489105T1 (de) Faktor ixa zur behandlung von blutungsstörungen
ATE285288T1 (de) Zusammengesetzte umkehrosmosemembranen und verfahren zu ihrer herstellung
ATE449104T1 (de) Verfahren zur reinigung von fibrinogen
DE50208601D1 (de) Verfahren zur aufreinigung von bakterienzellen und zellbestandteilen
ATE428942T1 (de) Verfahren und zusammensetzungen zur herstellung von ophtalmischen linsen
ATE256695T1 (de) Verfahren zur herstellung von pharmazeutisch annehmbaren salzen des (ss,rs)-s-adenosyl-l- menthionin
DE60134776D1 (de) Niederdruckumkehrosmose- und nanofiltrationsmembranen und verfahren für ihre herstellung
ATE465998T1 (de) Verfahren zur herstellung und reinigung von 1,7'- dimethyl-2'-propyl-2,5'-bi-1h-benzimidazol
DE60238056D1 (de) Verfahren zum kristallisieren von reduziertem coenzym q10 aus wässriger lösung
ATE271533T1 (de) Verfahren zur herstellung von alkincarbonsäuren durch oxidation von alkinalkoholen
FI973469A0 (fi) Menetelmä tekijän IX valmistamiseksi biologisista lähteistä
DE60004652D1 (de) Verfahren zur herstellung von gabapentin
ATE552234T1 (de) Cyclohexanderivate und verfahren zu deren herstellung
TW200517368A (en) Process
SE0201207D0 (sv) A process for production of a regioselective membrane
ATE341558T1 (de) Verfahren zur herstellung von topiramate
NO20082935L (no) Fremgangsmate for rensing av makrolidantibiotika